Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study

Detalhes bibliográficos
Autor(a) principal: Boarini, Lucas Rodrigues
Data de Publicação: 2023
Outros Autores: Sobrado, Carlos Walter, Mota, Giana Rabello, Villa, Luisa Lina, Albuquerque, Idblan Carvalho de, Queiroz, Natalia Sousa Freitas, Facanali, Carolina Bortolozzo Graciolli, Nadal, Sidney Roberto, Cecconello, Ivan
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/214001
Resumo: Background & Aims: Perianal fistulizing Crohn's disease is the main risk factor for anal cancer in patients with inflammatory bowel disease. Whether this occurs due to a higher frequency of human papillomavirus remains unclear. The authors aimed to evaluate the prevalence of HPV and high-risk HPV in patients with perianal Crohn's disease, compared with a control group. Methods: The authors conducted a two-center cross-sectional study in which perianal fistulizing Crohn's disease patients were matched for age and sex with patients with anorectal fistula without Crohn's disease. Biopsy specimens were obtained from fistulous tracts during examination under anesthesia for both groups. The samples were sent for HPV detection and genotyping using the INNO-LiPA test. Results: A total of 108 subjects (54 in each group) were recruited. The perianal fistulizing Crohn's disease group showed a statistically higher frequency of HPV in the fistulous tract than the control group (33.3% vs. 16.7%; p = 0.046). Separate analyses on high-risk types demonstrated that there was a numerically higher frequency of HPV in the perianal fistulizing Crohn's disease group. In multiple logistic regression, patients with perianal fistulizing Crohn's disease were found to have a chance of HPV 3.29 times higher than patients without Crohn's disease (OR = 3.29; 95% CI 1.20‒9.01), regardless of other variables. The types most frequently identified in the perianal fistulizing Crohn's disease group were HPV 11 (12.96%) and HPV 16 (9.26%). Conclusion: Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV than in patients with anorectal fistula without Crohn's disease.
id USP-19_7fe9311373de5d5d6eca3e2446491d81
oai_identifier_str oai:revistas.usp.br:article/214001
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative studyCrohn's DiseaseHPV (Human Papilloma Virus)Anal CancerBackground & Aims: Perianal fistulizing Crohn's disease is the main risk factor for anal cancer in patients with inflammatory bowel disease. Whether this occurs due to a higher frequency of human papillomavirus remains unclear. The authors aimed to evaluate the prevalence of HPV and high-risk HPV in patients with perianal Crohn's disease, compared with a control group. Methods: The authors conducted a two-center cross-sectional study in which perianal fistulizing Crohn's disease patients were matched for age and sex with patients with anorectal fistula without Crohn's disease. Biopsy specimens were obtained from fistulous tracts during examination under anesthesia for both groups. The samples were sent for HPV detection and genotyping using the INNO-LiPA test. Results: A total of 108 subjects (54 in each group) were recruited. The perianal fistulizing Crohn's disease group showed a statistically higher frequency of HPV in the fistulous tract than the control group (33.3% vs. 16.7%; p = 0.046). Separate analyses on high-risk types demonstrated that there was a numerically higher frequency of HPV in the perianal fistulizing Crohn's disease group. In multiple logistic regression, patients with perianal fistulizing Crohn's disease were found to have a chance of HPV 3.29 times higher than patients without Crohn's disease (OR = 3.29; 95% CI 1.20‒9.01), regardless of other variables. The types most frequently identified in the perianal fistulizing Crohn's disease group were HPV 11 (12.96%) and HPV 16 (9.26%). Conclusion: Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV than in patients with anorectal fistula without Crohn's disease.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2023-05-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21400110.1016/j.clinsp.2023.100219Clinics; Vol. 78 (2023); 100219Clinics; v. 78 (2023); 100219Clinics; Vol. 78 (2023); 1002191980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/214001/196212Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessBoarini, Lucas RodriguesSobrado, Carlos WalterMota, Giana RabelloVilla, Luisa LinaAlbuquerque, Idblan Carvalho deQueiroz, Natalia Sousa FreitasFacanali, Carolina Bortolozzo GraciolliNadal, Sidney RobertoCecconello, Ivan2023-07-06T13:05:39Zoai:revistas.usp.br:article/214001Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:05:39Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
title Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
spellingShingle Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
Boarini, Lucas Rodrigues
Crohn's Disease
HPV (Human Papilloma Virus)
Anal Cancer
title_short Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
title_full Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
title_fullStr Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
title_full_unstemmed Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
title_sort Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
author Boarini, Lucas Rodrigues
author_facet Boarini, Lucas Rodrigues
Sobrado, Carlos Walter
Mota, Giana Rabello
Villa, Luisa Lina
Albuquerque, Idblan Carvalho de
Queiroz, Natalia Sousa Freitas
Facanali, Carolina Bortolozzo Graciolli
Nadal, Sidney Roberto
Cecconello, Ivan
author_role author
author2 Sobrado, Carlos Walter
Mota, Giana Rabello
Villa, Luisa Lina
Albuquerque, Idblan Carvalho de
Queiroz, Natalia Sousa Freitas
Facanali, Carolina Bortolozzo Graciolli
Nadal, Sidney Roberto
Cecconello, Ivan
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Boarini, Lucas Rodrigues
Sobrado, Carlos Walter
Mota, Giana Rabello
Villa, Luisa Lina
Albuquerque, Idblan Carvalho de
Queiroz, Natalia Sousa Freitas
Facanali, Carolina Bortolozzo Graciolli
Nadal, Sidney Roberto
Cecconello, Ivan
dc.subject.por.fl_str_mv Crohn's Disease
HPV (Human Papilloma Virus)
Anal Cancer
topic Crohn's Disease
HPV (Human Papilloma Virus)
Anal Cancer
description Background & Aims: Perianal fistulizing Crohn's disease is the main risk factor for anal cancer in patients with inflammatory bowel disease. Whether this occurs due to a higher frequency of human papillomavirus remains unclear. The authors aimed to evaluate the prevalence of HPV and high-risk HPV in patients with perianal Crohn's disease, compared with a control group. Methods: The authors conducted a two-center cross-sectional study in which perianal fistulizing Crohn's disease patients were matched for age and sex with patients with anorectal fistula without Crohn's disease. Biopsy specimens were obtained from fistulous tracts during examination under anesthesia for both groups. The samples were sent for HPV detection and genotyping using the INNO-LiPA test. Results: A total of 108 subjects (54 in each group) were recruited. The perianal fistulizing Crohn's disease group showed a statistically higher frequency of HPV in the fistulous tract than the control group (33.3% vs. 16.7%; p = 0.046). Separate analyses on high-risk types demonstrated that there was a numerically higher frequency of HPV in the perianal fistulizing Crohn's disease group. In multiple logistic regression, patients with perianal fistulizing Crohn's disease were found to have a chance of HPV 3.29 times higher than patients without Crohn's disease (OR = 3.29; 95% CI 1.20‒9.01), regardless of other variables. The types most frequently identified in the perianal fistulizing Crohn's disease group were HPV 11 (12.96%) and HPV 16 (9.26%). Conclusion: Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV than in patients with anorectal fistula without Crohn's disease.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/214001
10.1016/j.clinsp.2023.100219
url https://www.revistas.usp.br/clinics/article/view/214001
identifier_str_mv 10.1016/j.clinsp.2023.100219
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/214001/196212
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 78 (2023); 100219
Clinics; v. 78 (2023); 100219
Clinics; Vol. 78 (2023); 100219
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222767388295168